What was the primary driver for the significant increase in revenue and net income during the period?

The primary driver for the substantial increase in revenue and net income for the three and six months ended June 30, 2006, was the acquisition of WellChoice, Inc., completed on December 28, 2005. This acquisition, along with organic growth from premium rate increases and new Medicare Part D enrollments, significantly boosted the company's top and bottom lines.

How has the acquisition of WellChoice affected the company's financial position, particularly its debt levels?

The acquisition of WellChoice significantly impacted the company's financial position. Long-term debt increased substantially, reflecting the financing used for the acquisition. Specifically, the company issued new debt totaling $2.7 billion in January 2006 to repay bridge loans and commercial paper used to fund the merger. The consolidated debt-to-total capital ratio rose to 24.3% as of June 30, 2006, from 21.4% at the end of 2005.

What are the company's key growth areas, and what initiatives are in place to manage costs?

Key growth areas include National Accounts, BlueCard membership, and specialty services such as pharmacy benefit management, driven partly by new Medicare Part D enrollments. To manage costs, Elevance Health is pursuing initiatives like contracting and plan design changes, promoting performance-based contracts, expanding radiology and disease management programs, and integrating care management tools through programs like 360º Health.

What is the significance of the company's stock repurchase program in this period?

The company actively engaged in a substantial stock repurchase program, spending $3.6 billion in the first six months of 2006 to buy back approximately 48.0 million shares. This program reflects a prudent use of surplus capital and aims to enhance shareholder value. As of June 30, 2006, $399.6 million remained authorized for future repurchases.

ELV 10-Q Quarterly Report Q2 FY2006 — Revenue, Net Income, EPS

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) reported a significant increase in total revenues for the three and six months ended June 30, 2006, driven primarily by the acquisition of WellChoice, Inc. and organic growth through premium rate increases and new Medicare Part D enrollment. Net income also saw a substantial rise, leading to improved earnings per share. The company's balance sheet reflects increased long-term debt following the WellChoice acquisition, offset by substantial share repurchases. Management highlights strong membership growth across various customer segments, particularly in National Accounts and BlueCard, alongside expansion in specialty services like pharmacy benefit management. The company is also actively managing costs through various initiatives, including program expansions and plan design changes, while maintaining a focus on a strong balance sheet and capital resources. Investors should note the impact of the WellChoice acquisition on financial results and the ongoing integration efforts.

Key Highlights

1Total revenues increased by 27% for the three months ended June 30, 2006, reaching $14.15 billion, and by 27% for the six months ended June 30, 2006, reaching $27.97 billion, largely due to the WellChoice acquisition and premium rate increases.
2Net income increased by 34% to $751.2 million for the three months and by 27% to $1,483.0 million for the six months ended June 30, 2006.
3Diluted earnings per share rose to $1.17 for the three months and $2.26 for the six months ended June 30, 2006, compared to $0.90 and $1.88, respectively, in the prior year.
4Total medical membership grew to 34.16 million as of June 30, 2006, an increase of 2% on a comparable basis, driven by growth in National Accounts and BlueCard segments.
5The company completed the acquisition of WellChoice, Inc. on December 28, 2005, for approximately $6.5 billion, which significantly impacted revenue and asset base.
6Elevance Health executed a substantial common stock repurchase program, spending $3.6 billion in the first six months of 2006.
7The company launched Medicare Part D Prescription Drug Plans effective January 1, 2006, enrolling approximately 1.5 million members by June 30, 2006.

Elevance Health, Inc. Quarterly Report for Q2 Ended Jun 30, 2006

Summary

Key Highlights

Frequently Asked Questions